Cargando…
Improving anti-cancer drug delivery performance of magnetic mesoporous silica nanocarriers for more efficient colorectal cancer therapy
BACKGROUND: Improving anti-cancer drug delivery performance can be achieved through designing smart and targeted drug delivery systems (DDSs). For this aim, it is important to evaluate overexpressed biomarkers in the tumor microenvironment (TME) for optimizing DDSs. MATERIALS AND METHODS: Herein, we...
Autores principales: | Iranpour, Sonia, Bahrami, Ahmad Reza, Nekooei, Sirous, Sh. Saljooghi, Amir, Matin, Maryam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507230/ https://www.ncbi.nlm.nih.gov/pubmed/34641857 http://dx.doi.org/10.1186/s12951-021-01056-3 |
Ejemplares similares
-
Using magnetic mesoporous silica nanoparticles armed with EpCAM aptamer as an efficient platform for specific delivery of 5-fluorouracil to colorectal cancer cells
por: Kamil Mohammad Al-Mosawi, Aseel, et al.
Publicado: (2023) -
Mesoporous Silica Nanomaterials: Versatile Nanocarriers for Cancer Theranostics and Drug and Gene Delivery
por: Kesse, Samuel, et al.
Publicado: (2019) -
High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery
por: Ultimo, Amelia, et al.
Publicado: (2023) -
Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine
por: Zhang, Chengcheng, et al.
Publicado: (2022) -
Mesoporous silica nanocarriers as drug delivery systems for anti-tubercular agents: a review
por: Tella, Josephine Oluwagbemisola, et al.
Publicado: (2022)